Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats

References

• Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165(10):1095–1106. doi:10.1001/archinte.165.10.1095
   PubMed Web of Science ®Google Scholar
• Chu Y, Zhang L, Wang XY, Guo JH, Guo ZX, Ma XH. The effect of compound danshen dripping pills, a Chinese herb medicine, on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Ethnopharmacol. 2011;137(3):1457–1461. doi:10.1016/j.jep.2011.08.035
   Web of Science ®Google Scholar
• Lehmann DF. Enzymatic shunting: resolving the acetaminophen-warfarin controversy. Pharmacotherapy. 2000;20(12):1464–1468. doi:10.1592/phco.20.19.1464.34860
   Web of Science ®Google Scholar
• Guo C, Xue S, Zheng X, et al. The effect of fenofibric acid on the pharmacokinetics and pharmacodynamics of warfarin in rats. Xenobiotica. 2018;48(4):400–406. doi:10.1080/00498254.2017.1306760
   PubMed Web of Science ®Google Scholar
• Kaminsky LS, Zhang ZY. Human P450 metabolism of warfarin. Pharmacol Ther. 1997;73(1):67–74. doi:10.1016/s0163-7258(96)00140-4
   PubMed Web of Science ®Google Scholar
• Ufer M. Comparative pharmacokinetics of vitamin K antagonists. Clin Pharmacokinet. 2005;44(12):1227–1246. doi:10.2165/00003088-200544120-00003
   PubMed Web of Science ®Google Scholar
• Ufer M, Kammerer B, Kirchheiner J, Rane A, Svensson JO. Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography-mass spectrometry after solid-phase extraction. J Chromatogr B Anal Technol Biomed Life Sci. 2004;809(2):217–226. doi:10.1016/j.jchromb.2004.06.023
   PubMed Web of Science ®Google Scholar
• Zhou Q, Yau WP, Chan E. Enantioseparation of warfarin and its metabolites by capillary zone electrophoresis. Electrophoresis. 2003;24(15):2617–2626. doi:10.1002/elps.200305441
   Web of Science ®Google Scholar
• Zuo Z, Wo SK, Lo CM, Zhou L, Cheng G, You J. Simultaneous measurement of S-warfarin, R-warfarin, S-7-hydroxywarfarin and R-7-hydroxywarfarin in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2010;52(2):305–310. doi:10.1016/j.jpba.2010.01.005
   Web of Science ®Google Scholar
• Juurlink DN. Drug interactions with warfarin: what clinicians need to know. CMAJ. 2007;177(4):369–371. doi:10.1503/cmaj.070946
   Web of Science ®Google Scholar
• John J, John M, Wu L, Hsiao C, Abobo CV, Liang D. Effects of etravirine on the pharmacokinetics and pharmacodynamics of warfarin in rats. Br J Pharmacol. 2013;168(8):1851–1858. doi:10.1111/bph.12082
   Web of Science ®Google Scholar
• Eriksson N, Wadelius M. Prediction of warfarin dose: why, when and how? Pharmacogenomics. 2012;13(4):429–440. doi:10.2217/pgs.11.184
   Web of Science ®Google Scholar
• Mazzari ALDA, Prieto JM. Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions. Front Pharmacol. 2014;9(5):162. doi:10.3389/fphar.2014.00162
   Web of Science ®Google Scholar
• Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280(18):1569–1575. doi:10.1001/jama.280.18.1569
   PubMed Web of Science ®Google Scholar
• Gardiner P, Phillips R, Shaughnessy AF. Herbal and dietary supplement-drug interactions in patients with chronic illnesses. Am Fam Physician. 2008;77(1):73–78.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Ades PA. Interactions of herbal remedies with prescription cardiovascular medications. Coron Artery Dis. 2001;12(7):581–584. doi:10.1097/00019501-200111000-00009
   Web of Science ®Google Scholar
• Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998;158(20):2200–2211. doi:10.1001/archinte.158.20.2200
   PubMed Web of Science ®Google Scholar
• Srinivasan K. Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr. 2007;47(8):735–748. doi:10.1080/10408390601062054
   PubMed Web of Science ®Google Scholar
• Moses G. What’s in complementary medicines? Aust Prescr. 2019;42(3):82–83. doi:10.18773/austprescr.2019.024
   Web of Science ®Google Scholar
• Borre YE, Panagaki T, Koelink PJ, et al. Neuroprotective and cognitive enhancing effects of a multi-targeted food intervention in an animal model of neurodegeneration and depression. Neuropharmacology. 2014;79:738–749. doi:10.1016/j.neuropharm.2013.11.009
   PubMed Web of Science ®Google Scholar
• Thiel A, Buskens C, Woehrle T, et al. Black pepper constituent piperine: genotoxicity studies in vitro and in vivo. Food Chem Toxicol. 2014;66:350–357. doi:10.1016/j.fct.2014.01.056
   PubMed Web of Science ®Google Scholar
• Bhat BG, Chandrasekhara N. Lack of adverse influence of black pepper, its oleoresin and piperine in the weanling rat. J Food Saf. 1986;7(4):215–223. doi:10.1111/j.1745-4565.1986.tb00543.x
   Web of Science ®Google Scholar
• Ganesh Bhat B, Chandrasekhara N. Studies on the metabolism of piperine: absorption, tissue distribution and excretion of urinary conjugates in rats. Toxicology. 1986;40(1):83–92. doi:10.1016/0300-483X(86)90048-X
   Web of Science ®Google Scholar
• Piyachaturawat P, Glinsukon T, Toskulkao C. Acute and subacute toxicity of piperine in mice, rats and hamsters. Toxicol Lett. 1983;16(3–4):351–359. doi:10.1016/0378-4274(83)90198-4
   PubMed Web of Science ®Google Scholar
• Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther. 2002;302(2):645–50.
   PubMed Web of Science ®Google Scholar
• Wadhwa S, Singhal S, Rawat S. Bioavailability enhancement by piperine: a review. AJBPS. 2014;4:36.
   Google Scholar
• Volak LP, Ghirmai S, Cashman JR, Court MH. Curcuminoids inhibit multiple human cytochromes P450 (CYP), UDP-glucuronosyltransferase (UGT), and sulfotransferase (SULT) enzymes, while piperine is a relatively selective CYP3A4 inhibitor. Drug Metab Dispos. 2008;36(8):1594–1605. doi:10.1124/dmd.108.020552
   PubMed Web of Science ®Google Scholar
• Shamsi S, Tran H, Tan RS, Tan ZJ, Lim LY. Curcumin, piperine, and capsaicin: a comparative study of spice-mediated inhibition of human cytochrome P450 isozyme activities. Drug Metab Dispos. 2017;45(1):49–55. doi:10.1124/dmd.116.073213
   PubMed Web of Science ®Google Scholar
• Hiwale AR, Dhuley JN, Naik SR. Effect of co-administration of piperine on pharmacokinetics of β-lactam antibiotics in rats. Indian J Exp Biol. 2002;40(3):277–281.
   PubMedGoogle Scholar
• Johnson JJ, Nihal M, Siddiqui IA, et al. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res. 2011;55(8):1169–1176. doi:10.1002/mnfr.201100117
   PubMed Web of Science ®Google Scholar
• Bano G, Raina R, Zutshi U, Bedi K, Johri R, Sharma S. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol. 1991;41(6):615–617. doi:10.1007/BF00314996
   PubMed Web of Science ®Google Scholar
• Singh A, Verma S, Al Jarari NMH, et al. Effect of piperine on pharmacokinetics of rifampicin and isoniazid: development and validation of high performance liquid chromatography method. J Appl Pharm Sci. 2018;8(3):72–81. doi:10.7324/JAPS.2018.8311
   Google Scholar
• Chen XY, Yang GH, Li CL, et al. Pharmacokinetic interaction between magnolol and piperine in rats. Trop J Pharm Res. 2016;15(3):631–638. doi:10.4314/tjpr.v15i3.27
   Web of Science ®Google Scholar
• Chopra B, Dhingra AK, Kapoor RP, Prasad DN. Piperine and its various physicochemical and biological aspects: a review. Open Chem J. 2017;3(1):75–96. doi:10.2174/1874842201603010075
   Google Scholar
• Frymoyer A, Shugarts S, Browne M, Wu AH, Frassetto L, Benet LZ. Effect of single-dose rifampin on the pharmacokinetics of warfarin in healthy volunteers. Clin Pharmacol Ther. 2010;88(4):540–547. doi:10.1038/clpt.2010.142
   Web of Science ®Google Scholar
• Bedada SK, Boga PK. The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers. Eur J Clin Pharmacol. 2017;73(3):343–349. doi:10.1007/s00228-016-2173-3
   PubMed Web of Science ®Google Scholar
• Feng X, Liu Y, Wang X, Di X. Effects of piperine on the intestinal permeability and pharmacokinetics of linarin in rats. Molecules. 2014;19(5):5624–5633. doi:10.3390/molecules19055624
   PubMed Web of Science ®Google Scholar
• Athukuri BL, Neerati P. Enhanced oral bioavailability of domperidone with piperine in male wistar rats: involvement of CYP3A1 and P-gp inhibition. J Pharm Pharm Sci. 2017;20:28–37. doi:10.18433/j3mk72
   PubMed Web of Science ®Google Scholar
• Jin MJ, Han HK. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction. J Food Sci. 2010;75(3):H93–6. doi:10.1111/j.1750-3841.2010.01542.x
   PubMed Web of Science ®Google Scholar
• Dubey RK, Leeners B, Imthurn B, Merki-Feld GS, Rosselli M. Piperine decreases binding of drugs to human plasma and increases uptake by brain microvascular endothelial cells. Phytother Res. 2017;31(12):1868–1874. doi:10.1002/ptr.5929
   Web of Science ®Google Scholar
• Ogiso T, Iwaki M, Tanaka H, et al. Pharmacokinetic drug interactions between ampiroxicam and sulfaphenazole in rats. Biol Pharm Bull. 1999;22(2):191–196. doi:10.1248/bpb.22.191
   Web of Science ®Google Scholar
• Wang L, Wang S, Chen M, et al. Inhibitory effect of ketoconazole and voriconazole on the pharmacokinetics of carvedilol in rats. Drug Dev Ind Pharm. 2015;41(10):1661–1666. doi:10.3109/03639045.2014.983930
   PubMed Web of Science ®Google Scholar
• Zayed A, Babaresh W, Darweesh R, El-Elimat T. Simultaneous determination of warfarin and 7-hydroxywarfarin in rat plasma by HPLC-FLD. Acta Pharm. 2019;70(2020):343–357. doi:10.2478/acph-2020-0025
   Web of Science ®Google Scholar
• De Oliveira RG, Vasconcellos MLAA, Alencar-Filho EB. [The influence of piperine on the bioavailability of drugs: a molecular approach]. Quim Nova. 2014;37(1):69–73. Portuguese. doi:10.1590/S0100-40422014000100013
   Web of Science ®Google Scholar
• Volak LP, Hanley MJ, Masse G, et al. Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers. Br J Clin Pharmacol. 2013;75(2):450–462. doi:10.1111/j.1365-2125.2012.04364.x
   PubMed Web of Science ®Google Scholar
• Bhardwaj RK, Glaeser H, Becquemont L, et al. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther. 2002;302(2):645–650. doi:10.1124/jpet.102.034728
   PubMed Web of Science ®Google Scholar
• Toutain PL, Bousquet-Melou A. Free drug fraction vs. free drug concentration: a matter of frequent confusion. J Vet Pharmacol Ther. 2002;25(6):460–463. doi:10.1046/j.1365-2885.2002.00442.x
   Web of Science ®Google Scholar
• Ding T, Zhang Y, Chen A, Tang Y, Liu M, Wang X. Effects of cucurbitacin E, a tetracyclic triterpene compound from cucurbitaceae, on the pharmacokinetics and pharmacodynamics of warfarin in rats. Basic Clin Pharmacol Toxicol. 2015;116(5):385–389. doi:10.1111/bcpt.12329
   PubMed Web of Science ®Google Scholar
• Cheong J, Halladay JS, Plise E, Sodhi JK, Salphati L. The effects of drug metabolizing enzyme inhibitors on hepatic efflux and uptake transporters. Drug Metab Lett. 2017;11(2):111–118. doi:10.2174/1872312811666171010101248
   PubMedGoogle Scholar
• Gschwind L, Rollason V, Daali Y, Bonnabry P, Dayer P, Desmeules JA. Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the caco-2 cell model. Basic Clin Pharmacol Toxicol. 2013;113(4):259–265. doi:10.1111/bcpt.12084.
   PubMed Web of Science ®Google Scholar